The trading price of Lexeo Therapeutics Inc (NASDAQ:LXEO) closed lower on Tuesday, May 06, and closing at $3.25, -26.97% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $19.50 and a 52-week low of $1.45. Over the past month, the stock has gained 39.19% in value.
Lexeo Therapeutics Inc, whose market valuation is $107.89 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest LXEO has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned LXEO a recommendation rating is 2. Out of them, 0 rate it a Hold, while 2 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Lexeo Therapeutics Inc (LXEO) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that LXEO’s price is currently 2.43% off the SMA20 and 5.05% off the SMA50. The RSI metric on the 14-day chart is currently showing 47.87, and weekly volatility stands at 25.16%. When measured over the past 30 days, the indicator reaches 23.05%. Lexeo Therapeutics Inc (NASDAQ:LXEO)’s beta value is currently sitting at 1.30, while the Average True Range indicator is currently displaying 0.63. With analysts defining $28-$28 as the low and high price targets, we arrive at a consensus price target of $28 for the trailing 12-month period. The current price is about -761.54% off the estimated low and -761.54% off the forecast high, based on this estimate. Investors will be thrilled if LXEO’s share price rises to $28, which is the median consensus price. At that level, LXEO’s share price would be -761.54% below current price.
To see how Lexeo Therapeutics Inc stock has been performing in comparison to its peers in the industry, here are the numbers: LXEO stock’s performance was -26.97% in the latest trading, and -73.92% in the past year.
An evaluation of the daily trading volume of Lexeo Therapeutics Inc (NASDAQ:LXEO) indicates that the 3-month average is 834.27K.
Currently, records show that 33.07 million of the company’s shares remain outstanding. The insiders hold 24.57% of outstanding shares, whereasinstitutions hold 88.59%. However, since the stock’s price has seen -50.61% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
